Vascular Cell Adhesion Molecule-1
"Vascular Cell Adhesion Molecule-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, p154)
| Descriptor ID |
D019010
|
| MeSH Number(s) |
D12.776.395.550.200.920 D12.776.543.550.200.920 D23.050.301.350.920
|
| Concept/Terms |
Vascular Cell Adhesion Molecule-1- Vascular Cell Adhesion Molecule-1
- Vascular Cell Adhesion Molecule 1
- Inducible Cell Adhesion Molecule 110
- CD106 Antigens
- VCAM-1
- CD106 Antigen
- Antigen, CD106
- Antigens, CD106
- Vascular Cell Adhesion Molecule
- INCAM-110
|
Below are MeSH descriptors whose meaning is more general than "Vascular Cell Adhesion Molecule-1".
Below are MeSH descriptors whose meaning is more specific than "Vascular Cell Adhesion Molecule-1".
This graph shows the total number of publications written about "Vascular Cell Adhesion Molecule-1" by people in this website by year, and whether "Vascular Cell Adhesion Molecule-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 1 | 4 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 1 | 3 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 3 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 3 | 4 |
| 2010 | 2 | 2 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 4 | 5 |
| 2015 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vascular Cell Adhesion Molecule-1" by people in Profiles.
-
Targeted deletion of NR2F2 and VCAM1 in theca cells impacts ovarian follicular development: insights into polycystic ovary syndrome??. Biol Reprod. 2024 Apr 11; 110(4):782-797.
-
Microvascular activation and exocytosis after exposure to the serum from mismatched recipients by using donor microvascular cultures. Transpl Immunol. 2024 02; 82:101963.
-
Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis. Front Immunol. 2022; 13:910993.
-
Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus. Front Immunol. 2022; 13:885307.
-
Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights. Curr Opin Rheumatol. 2022 03 01; 34(2):139-149.
-
Relationship of Circulating Endothelial Cells With Obesity and Cardiometabolic Risk Factors in Children and Adolescents. J Am Heart Assoc. 2021 01 05; 10(1):e018092.
-
An Allosteric Shift in CD11c Affinity Activates a Proatherogenic State in Arrested Intermediate Monocytes. J Immunol. 2020 11 15; 205(10):2806-2820.
-
ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. Rheumatology (Oxford). 2020 09 01; 59(9):2237-2249.
-
Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities. Nat Commun. 2020 05 04; 11(1):2197.
-
VCAM1 Is Induced in Ovarian Theca and Stromal Cells in a Mouse Model of Androgen Excess. Endocrinology. 2019 06 01; 160(6):1377-1393.